LEADER 00000cam a2200625Ma 4500 
001    ocn823743211 
003    OCoLC 
005    20160527041614.8 
006    m     o  d         
007    cr cn||||||||| 
008    121204s2012    xx      ob    001 0 eng d 
019    818819310 
020    1608054705|q(electronic book) 
020    9781608054701|q(electronic book) 
020    |z9781608054701 
020    |z9781608055944 
035    (OCoLC)823743211|z(OCoLC)818819310 
040    E7B|beng|epn|cE7B|dOCLCQ|dOCLCO|dOCLCF|dEBLCP|dK6U|dN$T
       |dBENTH|dYDXCP|dOCLCQ 
049    RIDW 
050  4 RC537|b.K66 2012eb 
072  7 HEA|x039000|2bisacsh 
072  7 MED|x014000|2bisacsh 
072  7 MED|x022000|2bisacsh 
072  7 MED|x112000|2bisacsh 
072  7 MED|x045000|2bisacsh 
082 04 616.8527 
090    RC537|b.K66 2012eb 
100 1  Knoll, J.|q(József)|0https://id.loc.gov/authorities/names/
       n50042379 
245 10 How selegiline (( - )-deprenyl) slows brain aging /
       |cauthored by Joseph Knoll. 
264  1 [Place of publication not identified] :|bBentham Science 
       Publishers,|c2012. 
300    1 online resource (xvi, 142 pages) 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
340    |gpolychrome|2rdacc 
347    text file|2rdaft 
504    Includes bibliographical references and indexes. 
505 0  Cover; Title; EUL; Contents; Foreword; Abbreviations; 
       Keywords; Introduction; Chapter 01; Chapter 02; Chapter 
       03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; 
       Chapter 08; Chapter 09; Summary and Conclusion; Epilogue; 
       References; Appendix; Author Index; Subject Index. 
520    This e-book is a reference on Selegiline (( - )-Deprenyl) 
       effects on the brain. Selegiline, described in thousands 
       of research papers, is registered in over 60 countries. At
       present, more than one hundred preparations containing 
       selegiline circulate in the global market under different 
       brand names. They are widely used in the treatment of 
       Parkinson's disease, Alzheimer's disease, major depression
       and as a geroprotective / anti-aging drug. (( - )-
       Deprenyl) selegiline, the first selective inhibitor of B-
       type MAO which, in contrast to the known MAO inhibitors, 
       did not potentiate the effect of tyra. 
590    eBooks on EBSCOhost|bEBSCO eBook Subscription Academic 
       Collection - North America 
650  0 Depression, Mental.|0https://id.loc.gov/authorities/
       subjects/sh85037053 
650  0 Brain|xAging.|0https://id.loc.gov/authorities/subjects/
       sh85016322 
650  0 Selegiline.|0https://id.loc.gov/authorities/subjects/
       sh87007222 
650  7 Depression, Mental.|2fast|0https://id.worldcat.org/fast/
       890931 
650  7 Brain|xAging.|2fast|0https://id.worldcat.org/fast/837575 
650  7 Selegiline.|2fast|0https://id.worldcat.org/fast/1111391 
655  4 Electronic books. 
776 08 |iPrint version:|aKnoll, Joseph.|tHow Selegiline (( - )-
       Deprenyl) Slows Brain Aging.|dSharjah : Bentham Science 
       Publishers, ©2012|z9781608055944 
856 40 |uhttps://rider.idm.oclc.org/login?url=http://
       search.ebscohost.com/login.aspx?direct=true&scope=site&
       db=nlebk&AN=500701|zOnline eBook. Access restricted to 
       current Rider University students, faculty, and staff. 
856 42 |3Instructions for reading/downloading this eBook|uhttp://
       guides.rider.edu/ebooks/ebsco 
901    MARCIVE 20231220 
948    |d20160607|cEBSCO|tebscoebooksacademic|lridw 
994    92|bRID